Every individual responds differently to medications, and their reactions can vary greatly. While a specific drug may be effective for one person with no adverse effects, another individual may experience a negative reaction to the same medication. Pharmacogenomic (PGx) testing enables the identification of patients who are prone to adverse drug reactions, individuals who are more likely to benefit from specific medications and those who may require adjusted dosages. As adverse drug reactions
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Q/A: AiCure SVP Talks How Digital Health Can Improve Access to Clinical Trials
The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. At the heart of this challenge lies the crucial necessity for clean and streamlined patient data, which currently suffers from inadequacies in comprehensiveness and accuracy. Addressing this pivotal issue carries immense benefits, particularly in the sphere of targeted trial recruitment efforts. By harnessing better patient data records, the possibilities
Read More
PacBio and GeneDx Launches Research Collaboration
What You Should Know:
PacBio, a developer of high-quality, highly accurate sequencing solutions and GeneDx, a provider in delivering improved health outcomes through genomic and clinical insights, today announced a research collaboration with the University of Washington to study the capabilities of HiFi long-read whole genome sequencing (WGS) to increase diagnostic rates in pediatric patients with genetic conditions.GeneDx will perform WGS sequencing and analysis of samples from 350
Read More
Walgreens Sells $1.85B of AmerisourceBergen Shares, Reduces Stake by 16%
What You Should Know:
Walgreens Boots Alliance announces the sale of shares of AmerisourceBergen Corporation valued at $1.85B for debt paydown and general corporate purposes.Walgreens Boots Alliance’s ownership stake of AmerisourceBergen’s common stock has not been impacted but is expected to decrease by to approximately 16 percent.
Read More
Safety Intelligence is Redefining How Pharmacovigilance Teams Operate
The future of safety intelligence is now. New safety reporting and analytics advancements have redefined how pharmacovigilance (PV) teams operate by putting next-generation safety intelligence at the fingertips of those needing it most.
Teams that can streamline data flow and enable stakeholders to self-service real-time insights are delivering unprecedented value by enabling greater case management visibility and more informed, proactive decision-making.
Despite this, many PV
Read More
Health Equity Gets Boost from Biosimilars and Evidence-Based Treatment
Eliminating healthcare inequities requires addressing the underlying social and economic factors that contribute to these disparities and ensuring that all individuals have equal access to high-quality healthcare services, regardless of their background or circumstances. This includes addressing issues such as poverty, discrimination, and unequal distribution of resources, as well as promoting health equity as a core value of healthcare systems.
In recent years, there’s been a shift in the
Read More
Steve Jobs’ Son Launches $200M Fund to Fight Against Cancer
What You Should Know:
Reed Jobs - the son of Steve Jobs today announced the launch of his new venture capital (VC) investment fund, Yosemite, spun out from Emerson Collective Health with an oversubscribed $200M+ first close.Yosemite aims to meaningfully accelerate the technology, treatments, and standard of care that have the power to improve the health and lives of cancer patients.Composed of the Emerson Health team, Yosemite’s unique model provides no-strings-attached
Read More
Where Has All The Talent Gone? The Skills Gap Stalling The March of UK Life Sciences
The UK life sciences industry is burgeoning and, thanks in part to the role played by Covid in supercharging a range of sectors, it is on a path toward further expansion. Rishi Sunak, the Prime Minister, recently stated his ambition for the country to become a life sciences ‘superpower’.
However, at a time of unprecedented development, the industry also finds itself at the center of a skills shortage that threatens to stall, or even halt, its trajectory.
This skills gap is not only a
Read More
S&T Researchers Developing 3D-Printed Dressings for Better Wound Care
What You Should Know:
- Missouri University of Science and Technology researchers are developing new 3D-printed hydrogel dressings to speed up and improve the healing process for patients with second-degree burns. The research team published an article covering their latest findings in the International Journal of Bioprinting in July.
- Hydrogels are typically part of the care regimen for patients with severe burns, but what separates S&T’s research from standard hydrogels is that the
Read More
M&A: New Day Diagnostics to Acquire the Assets of Epigenomics AG
What You Should Know:
New Day Diagnostics LLC announced it has entered into an agreement to acquire the assets of Epigenomics AG, a molecular diagnostics company focused on blood testing for the early detection of cancer.Under the terms of the agreement, New Day Diagnostics would acquire substantially all of Epigenomics AG’s assets and intellectual property. The acquisition would expand New Day Diagnostics' portfolio in the cancer diagnostics space and include proprietary biomarker
Read More
